N-[2-(Pyridin-2-yl)ethyl]-2,3-dihydro-1,4-benzodioxine-2-carboxamide

Catalog No. :
ACSBFF650
CAS No. :
865660-11-3
Molecular Formula :
C16H16N2O3
Molecular Weight :
284.32

IUPAC Name:N-(2-(pyridin-2-yl)ethyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide

N-[2-(Pyridin-2-yl)ethyl]-2,3-dihydro-1,4-benzodioxine-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[2-(Pyridin-2-yl)ethyl]-2,3-dihydro-1,4-benzodioxine-2-carboxamide
IUPAC NameN-(2-(pyridin-2-yl)ethyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide
MDL No.MFCD04125305
Molecular FormulaC16H16N2O3
Molecular Weight284.32
SMILESO=C(C1OC2=CC=CC=C2OC1)NCCC3=NC=CC=C3
InChI KeyDMZROXGUFDJHSR-UHFFFAOYSA-N
SynonymN-[2-(2-PYRIDINYL)ETHYL]-2,3-DIHYDRO-1,4-BENZODIOXINE-2-CARBOXAMIDE;N-[2-(pyridin-2-yl)ethyl]-2,3-dihydro-1,4-benzodioxine-2-carboxamide;1,4-Benzodioxin-2-carboxamide, 2,3-dihydro-N-[2-(2-pyridinyl)ethyl]-
CAS No.865660-11-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSBFF650 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVSCI231 route compound structure diagram
    ACVSCI2313663-80-7 In Stock
  4. Then
  5. ACSBFF650 route product structure diagram
    ACSBFF650865660-11-3
Inquiry

2. ACSBFF650 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSBFF650 route product structure diagram
    ACSBFF650865660-11-3
Inquiry

Comments (0)